Skip to content

Intrathecal hyperbaric bupivacaine versus hyperbaric ropivacaine in spinal anaesthesia in caesarean sections: a randomised control trial in a teaching hospital in northeast India.

Intrathecal hyperbaric bupivacaine versus hyperbaric ropivacaine in spinal anaesthesia in caesarean sections: a randomised control trial in a teaching hospital in northeast India. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067399
Enrollment
66
Registered
2024-05-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O298- Other complications of anesthesiaduring pregnancy

Interventions

Intervention1: Ropivacaine 0.75% hyperbaric solution: 2.4cc of injection ropivacaine 0.75% hyperbaric solution i.e 18mg For 12 hours duration Control Intervention1: Injection Bupivacaine 0.5% hyperbar

Sponsors

Neon
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: i. All patients who will be registered for elective caesarean delivery and belonging to ASA (American Society of Anesthesiologists) grade I & II only. ii. Patients between 145to 165 cms of height. iii. Patients who will give valid informed written consent. iv. Pregnancy over 37 weeks and less than 42 weeks. v. Patient with weight of 45-95kgs. vi. Patients with age between 18years and 40 years.

Exclusion criteria

Exclusion criteria: i. Patient with abnormalities and problems in the embryo. ii. Patient with indication of an emergency caesarean section. iii. Patients having history of hypersensitivity to anesthetic agents. iv. Infection at the subarachnoid block injection site. v. Pre-term and post term delivery. vi. ASA class higher than II.

Design outcomes

Primary

MeasureTime frame
To compare the onset of action, duration of sensory and motor block, and duration of effective analgesia induced by intrathecal hyperbaric ropivacaine and hyperbaric bupivacaine in patients undergoing elective caesarean section.Timepoint: 0,3,6,9,12,15,20,30,45,60,90,120,150,180,240,300,360,480,600,720 hours

Secondary

MeasureTime frame
1. To compare the haemodynamic variables in two groups during the intra operative & post operative period for 12 hours. 2. To evaluate & compare the adverse effects intra-operatively & post-operatively in the two groups. Timepoint: 0,3,6,9,12,15,20,30,45,60 min for haemodynamics Sensory & Motor blockade 15 minutes interval intraoperatively & post operatively

Countries

India

Contacts

Public ContactRanjit Reang

Agartala Government Medical College

dr.anupamc@gmail.com9436123689

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026